review

Cards (72)

  • Parasympathetic Nervous System
    • Preganglionic neurons from the cranial and sacral regions of the spinal cord synapse with the postganglionic neurons on an outside ganglia
    • Parasympathetic innervation results in pupil constriction, salivation, airway constriction, bradycardia, stomach digestion, intestinal digestion, bladder constriction, and reproductive system blood flow increase
    • This system typically innervates cardiac smooth muscle, gland cells, and nerve terminals
  • Cranial nerves involved in parasympathetic innervation
    • Oculomotor (3)
    • Facial (7)
    • Glossopharyngeal (9)
    • Vagus (10)
  • Sacral nerves involved in parasympathetic innervation
    • 2
    • 3
    • 4
  • NN receptors
    Located in the CNS, postganglionic cell body, and dendrites. Their structure is a pentamer with only ɑ and β subunits. They work through Na+ and K+ depolarization ion channels
  • NM receptors
    Located in the skeletal neuromuscular junction. Their structure is that of a pentamer with ɑ, β, γ, and δ subunits. They work through Na+ and K+ depolarization ion channels
  • M1 receptors
    Located in the nerves. Their structure is a Gq/11 protein coupled receptor. They work through the IP3 and DAG cascade. Has a stimulatory effect. Innervation causes the brain to increase cognition and memory while the stomach is told to increase pepsinogen and HCl release
  • M2 receptors
    Located in the heart, nerves, and smooth muscle. Their structure is a Gi/o protein coupled receptor. They work through cAMP inhibition and activation of K+ channels. Has an inhibitory effect. Causes the SA node to decrease chronotropy, atria to decrease inotropy, AV node to decrease dromotropy/increase refractory period, and the ventricles to decrease inotropy
  • M3 receptors
    Located in the glands, smooth muscles, and endothelial cells. Their structure is a Gq/11 protein coupled receptor. They work through the IP3 and DAG cascade. Has a stimulatory effect. Causes increased tears, saliva, bronchial secretions and constriction, digestive enzymes, GI mucus and peristalsis, iris miosis and lens, and increases detrusor contraction/trigone and sphincter relaxation
  • M4 receptors
    Located in the CNS. Their structure is a Gi/o protein coupled receptor. They work through cAMP inhibition and activation of K+ channels
  • M5 receptors
    Located in the CNS. Their structure is a Gq/11 protein coupled receptor. They work through the IP3 and DAG cascade
  • Cholinomimetics
    • Direct Acting: Muscarinic and nicotinic receptor agonists
    • Indirect Acting: Cholinesterase inhibitors
  • Nicotine
    • Works on the ɑ4, ɑ7 and β2 subunits of nicotinic receptors
    • In the brain, it causes dopaminergic receptors to release dopamine causes euphoria, but also dependence
    • Drug is slowly absorbed transdermally and mucosal dosage forms
  • Varenicline
    • Partial nicotinic acetylcholine receptor agonist producing a modest dopamine release while blocking real nicotine from binding
    • This drug is well tolerated, but can lead to some nausea, vomiting, abnormal dreams, depression, headache, insomnia, and irritability
    • This drug is mainly excreted in the urine unchanged
  • Cholinergic Toxidrome
    • S - Salivation
    • L - Lacrimation
    • U - Urination
    • D - Diaphoresis
    • G - GI Upset
    • E - Emesis
    • M - Miosis
    • B - Bradycardia
  • Bethanechol
    • Direct M3 agonist that stimulates bladder contraction
    • This drug is a quaternary amine, meaning it cannot cross the blood brain barrier
    • This drug can also cause abdominal pain, colicky pain, nausea, diarrhea, and borborygmi
  • Carbachol
    • Directly stimulates M1 and M2 to decrease intraocular pressure and constrict the iris
    • May cause blurred vision and ocular irritation
  • Methacholine
    • Works by directly acting on M2 and M3 receptor to cause smooth muscle contraction in the airways and increased bronchial secretions during stress tests
    • Used to diagnosis respiratory diseases, not used as their treatment
    • May cause bronchoconstriction when given, but has a short duration of action of ~30 minutes
  • Cevimeline
    • Direct agonist of M1 and M3 that results in increased saliva, sweat, and smooth muscle contractions in the glands
    • Adverse effects include diarrhea and hyperhidrosis
  • Pilocarpine
    • Directly agonizes M1, M2, and M3 receptors leading to ciliary muscle contraction in open-angle glaucoma, opening of the angle in closed-angle glaucoma, and increasing salivary to treat xerostomia
    • Adverse effects are only hyperhidrosis since they're less likely to occur with eye drops
  • Myasthenia Gravis
    • Autoimmune disease that attacks nicotinic receptors in the skeletal neuromuscular junction. This can happen by receptor cross-linking, lysis of the postsynaptic membrane, and/or binding directly to the receptors and inhibiting their function
    • Symptoms: Ptosis, diplopia, muscle weakness, and trouble speaking
    • This disease is treated by AChE inhibitors which increase ACh in the synaptic cleft
  • Neostigmine
    • Reversible AChE inhibitor
    • This drug does not cross the blood brain barrier
    • Used to treat myasthenia gravis but has SLUDGE MB side effects
  • Physostigmine
    • Reversible AChE inhibitor
    • This drug does cross the blood brain barrier
    • Used to treat anticholinergic poisoning
  • Pyridostigmine
    • Reversible AChE inhibitor
    • Used to treat myasthenia gravis and neuromuscular blockade with SLUDGE MB side effects
  • Alzheimer's Disease
    • Characterized by the impaired release of ACh and deficits in the expression of nicotinic and muscarinic receptors
    • AChE inhibitors are typically used to treat this disease by prolonging the half-life of ACh in the synaptic cleft
  • Donepezil
    • Reversible AChE inhibitor
    • This drug does cross the blood brain barrier
    • Used to treat Alzheimer's disease with SLUDGE MB side effects
  • Galantamine
    • Reversible AChE inhibitor and also a positive allosteric modulator of neuronal nicotinic ACh receptors
    • This drug does cross the blood brain barrier
    • Used to treat Alzheimer's disease with dermatological and SLUDGE MB side effects
  • Rivastigmine
    • Reversible AChE inhibitor
    • Used to treat Alzheimer's disease and Parkinson's disease
    • Adverse drug reactions are SLUDGE MB
  • Anticholinergic Toxidrome
    • Flushed skin 'red as a beat'
    • Xerostomia 'dry as a bone'
    • Mydriasis 'blind as a bat'
    • Confusion ' mad as a hatter'
    • Hyperthermia ' hot as a desert'
    • Urinary retention 'full as a flask'
  • Anticholinergic drugs have a high risk of cognitive impairment and tend to lead to dementia if used for long-term
  • Scopolamine
    • Competitive antagonist at muscarinic receptor
    • This drug does cross the blood brain barrier
    • Used to reduce vertigo and nausea
    • Adverse drug reactions are tachycardia, blurred vision, xerostomia, and delirium
  • Dicyclomine
    • Competitive antagonist at the M1 and M4 receptors that reduces smooth muscle and secretory activity of the gut
    • Likely well absorbed into the body unlike other anticholinergic drugs
    • Used for IBS and minor diarrhea
    • Adverse drug reactions are tachycardia, confusion, urinary retention, and increase intraocular pressure
  • Atropine
    • Competitive muscarinic receptor antagonist that relaxes the iris sphincter and ciliary body
    • Has a high duration of action , up to 2 weeks
    • Used for secretions that happen towards the end of the life
    • Anti-SLUDGE MB adverse reactions might happen
  • Ipratropium
    • Competitive muscarinic receptor antagonist of the M3 receptor to reduce bronchospasm
    • This drug is quaternary amine so it does not cross the blood brain barrier
    • Used for rhinorrhea and asthma and mainly causes xerostomia and cough
  • Oxybutynin
    • Muscarinic antagonist that reduces detrusor muscle tone and spasms
    • Used for incontinence and postoperative spasms
    • This medication does cross the blood brain barrier to a high degree
  • Atropine
    Eye drops that are a competitive muscarinic receptor antagonist that relaxes the iris sphincter and ciliary body
  • Atropine
    • Has a high duration of action, up to 2 weeks
    • Used for secretions that happen towards the end of life
  • Atropine adverse reactions may include anti-SLUDGE MB
  • Ipratropium (Atrovent)
    Competitive muscarinic receptor antagonist of the M3 receptor to reduce bronchospasm
  • Ipratropium is a quaternary amine so it does not cross the blood brain barrier
  • Ipratropium
    Used for rhinorrhea and asthma, mainly causes xerostomia and cough